Fluid Biotech Inc.
$50,000.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2019-2020
- Agreement period
- October 1, 2019 – March 31, 2020
- Reference
- nrc-cnrc:172-2019-2020-Q3-935585
Published purpose
Fluid Biotech is developing a bioabsorbable flow-diverting dissolving intravascular stent as an innovative way to treat patients with brain aneurysms. This project will result in the validation of medium-term safety and efficacy of the Fluid Biotech stent for the treatment of aneurysms in an animal model. Second key element is to contract and work closely with regulatory experts at TEC Edmonton to co-develop a regulatory framework and workplan for presentation to Health Canada and FDA at pre-submission meetings.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported July 30, 2026 from open.canada.ca Grants & Contributions